[No selection of mutations. 908 raises genetic resistance barrier].
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000821:virology; D002219:Carbamates; D004252:DNA Mutational Analysis; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D005663:Furans; D016333:HIV Protease / Q000235:genetics*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D006801:Humans; D019888:Nelfinavir / Q000008:administration & dosage* / Q000009:adverse effects; D010755:Organophosphates / Q000008:administration & dosage* / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage* / Q000009:adverse effects; D014779:Virus Replication / Q000187:drug effects / Q000235:genetics
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D010755:Organophosphates; D013449:Sulfonamides; D054303:HIV Reverse Transcriptase; D016333:HIV Protease; D019888:Nelfinavir; C426859:fosamprenavir